Explore Henry Schein's Q4 2024 earnings insights, including strategic growth plans, KKR partnership, and financial performance.
Henry Schein forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid persistent inflation.
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical ...
Reports Q4 revenue $3.19B, consensus $3.25B. “Our fourth quarter financial results reflect relatively stable dental and medical end-markets. We ...
The company will also have the option to increase its equity stake up to 14.9% through open market purchases. Henry Schein and KKR will collaborate on a ...
The bigger picture: Strategic shifts amid financial pressures. KKR's investment in Henry Schein suggests a shift towards more aggressive strategies to tackle competitive and market challenges. Changes ...
Piper Sandler holds a 4Q recap discussion on a conference call with management on March 4. Discover the Best Stocks and Maximize Your ...